Home
About
Services
Partners
Client Portfolio
News
Contact
Cloud, services fuel IBM’s profit beat, robust outlook; shares jump
January 22, 2019
BlackRock plans environmentally conscious money market fund
January 22, 2019
0
J&J forecasts disappointing 2019 sales, defends talc safety
Published by
Muller&Green
at
January 22, 2019
Categories
RSS
Tags
Johnson & Johnson on Tuesday forecast 2019 sales that fell short of analysts’ estimates and said it expected further pressure on U.S. prescription drug prices, weighing on the broader pharmaceutical sector.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more